相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Name Changes for Fungi of Medical Importance, 2018 to 2019
Andrew M. Borman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
Antifungal Resistance among Less Prevalent Candida Non-albicans and Other Yeasts versus Established and under Development Agents: A Literature Review
Ana Espinel-Ingroff et al.
JOURNAL OF FUNGI (2021)
Comparative Pharmacodynamics of Echinocandins against Aspergillus fumigatus Using an In Vitro Pharmacokinetic/Pharmacodynamic Model That Correlates with Clinical Response to Caspofungin Therapy: Is There a Place for Dose Optimization?
Maria Siopi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method
Andrew M. Borman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Drug resistance and tolerance in fungi
Judith Berman et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Should Etest MICs for Yeasts Be Categorized by Reference (BPs/ECVs) or by Etest (ECVs) Cutoffs as Determinants of Emerging Resistance?
A. Espinel-Ingroff et al.
CURRENT FUNGAL INFECTION REPORTS (2020)
Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex
M. Salse et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review
Eric Dannaoui et al.
JOURNAL OF FUNGI (2019)
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
A. J. Ullmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Invasive candidiasis
Peter C. Pappas et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?
Mariana I. D. S. Xisto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida albicans
Zhongle Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database
Mark Fraser et al.
MEDICAL MYCOLOGY (2016)
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Thomas F. Patterson et al.
CLINICAL INFECTIOUS DISEASES (2016)
The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds
Ana Espinel-Ingroff et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2016)
Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy
Sandra A. Asner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Stephanie A. Flowers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA
Dong Sik Jung et al.
EMERGING INFECTIOUS DISEASES (2015)
Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Candida tropicalis Antifungal Cross-Resistance Is Related to Different Azole Target (Erg11p) Modifications
A. Forastiero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature
Florent Morio et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values
J Turnidge et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance
M Sanguinetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
S Perea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest
F Peyron et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
分享论文
